China Takayasu Arteritis Registry (CTA Registry)

Recruiting Observational Study
TAKAYASU ARTERITIS
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 – 80
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Aimin Dang · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Takayasu arteritis (TA) is a chronic large-vessel vasculitis that mainly affects the aorta and its major branches. The epidemiology and pathophysiology of TA is still unclear in China, although many studies have been done. Our previous study supporting by National Natural Science Foundation of China indicated the cytokines such as hs-CRP, NT-proBNP and tumor necrosis factor-alpha (TNF-α) can be us…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age at disease onset \< 40 years. (Development of symptoms or findings related to Takayasu arteritis at age \<40 years) * Claudication of extremities. (Development and worsening of fatigue and discomfort in muscles of 1 or more extremity while in use, especially the upper extr…
Contacts

Aimin Dang, MD,PhD

+8610-88322131

aimindangfw@gmail.com

CONTACT

Naqiang lv, MD,PhD

+8610-88322131

lvnaqiang@gmail.com

CONTACT